Only CD19 ( + ) / CD24 ( high ) / CD38 ( high ) / CD27 ( + ) and CD19 ( + ) / CD24 ( high ) / CD38 ( high ) / CXCR7 ( + ) cells had significant higher frequency in patients under cycloporine treatment when compared to those under belatacept .